Apyx medical corp (APYX)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Net loss

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash flows from operating activities
Net income (loss)

-

-

-

-

-

-

-

-

-

-

-

0

-3,691

-

-4,835

-5,458

-6,438

-5,370

-9,153

-10,301

-8,551

-17,282

-14,561

-12,166

-13,537

-4,339

-1,584

-1,251

21

617

0

0

0

-

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

774

754

750

614

664

669

598

711

717

696

705

735

730

734

737

746

777

812

851

844

861

876

863

864

847

827

722

718

730

742

716

740

748

753

0

0

0

Provision for inventory obsolescence

101

132

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Provision for inventory obsolescence

-

-

-

-

-

-

-

-

-

-

-

0

-255

-

564

629

643

157

-294

-300

603

733

957

910

67

12

-34

-52

-67

-93

-16

-66

-49

37

0

0

0

Gain on disposal of property and equipment, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-21

-22

-35

-27

-21

-43

-16

-18

-14

-2

-14

-11

-16

0

0

0

-

-

-

-

-

-

-

-

Loss on disposal of property and equipment, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

Stock based compensation

3,435

3,581

3,580

3,190

3,047

2,224

1,577

1,279

1,084

871

808

790

792

809

728

693

633

575

490

479

424

388

436

363

538

506

400

391

179

161

136

129

123

132

0

0

0

Change in fair value of derivative liabilities

-

-

-

-

-

-20

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized gain on short term investments

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized gain on short term investments

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of derivative liabilities

-

-

-

-

-

-

-

-

-

-

-

0

65

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Provision (benefit) for allowance for doubtful accounts

399

-163

7

-15

-5

224

174

102

177

179

86

84

-29

84

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Benefit of deferred taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non cash other (income) loss - warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

Benefit (provision) for deferred taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-2,438

-1,260

-1,230

-1,613

-1,163

-896

-269

210

0

0

0

-

-

-

0

Changes in operating assets and liabilities:
Trade receivables

2,365

3,970

3,622

676

255

447

236

765

1,041

303

296

1,509

1,111

1,894

1,567

1,720

1,945

1,029

498

586

-439

-90

-162

-1,011

-181

-884

-542

-250

-639

658

478

427

21

126

0

0

0

Prepaid expenses and other assets

6,081

406

0

0

0

-

-

-

-

30

70

2

105

-103

-261

-425

-475

-286

340

730

903

259

-187

-708

-1,010

-406

-360

-115

-3

241

0

0

0

-

-

-

0

Prepaid expenses

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventories

3,052

2,367

-428

-976

-1,151

-1,185

897

-132

-736

368

1,041

916

428

201

78

408

788

102

-2,541

-2,067

-1,723

-1,955

809

783

428

884

1,149

1,279

429

-287

218

183

698

719

0

0

0

Deposits and other assets

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deposits and other assets

-

-

-

-

-

-

-

-

-

-

-

225

300

341

506

400

366

228

257

994

1,056

952

858

-27

-183

-234

0

0

0

-

-

-

-

-

-

-

-

Deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

0

Accounts payable

1,080

1,054

-939

-1,168

-657

-224

961

668

-79

-23

-263

303

634

392

-541

181

-184

-189

971

713

846

494

200

203

146

257

552

184

162

-284

-94

-302

-52

134

0

0

0

Accrued severance and related

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Litigation settlement liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

Accrued and other liabilities

555

2,370

-11,948

-13,839

-14,534

-15,341

-877

-60

831

710

850

698

-36

763

111

595

451

553

806

863

628

455

-234

-774

402

742

510

672

-156

-403

-418

-301

-431

-30

0

0

0

Accrued payroll

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Accrued vacation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Net cash used in operating activities

-20,793

-18,475

-33,140

-29,341

-24,862

-20,881

-2,104

-1,491

-1,994

-3,704

-4,979

-4,351

-3,388

-2,837

-3,314

-4,045

-6,262

-5,786

-4,567

-3,225

-1,159

-417

-1,962

-2,582

-3,332

-2,536

-1,178

-1,556

398

165

-94

134

674

1,897

0

0

0

Cash flows from investing activities
Purchases of property and equipment

1,274

1,301

1,236

953

341

363

396

805

692

624

535

396

336

286

-1

0

188

421

915

928

809

630

490

459

532

588

721

759

641

753

532

568

710

542

0

0

0

Purchases of marketable securities

0

18,884

50,640

106,073

106,073

87,189

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from maturities of marketable securities

40,884

80,726

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in) provided by investing activities

39,610

60,541

54,608

90,553

50,281

29,301

35,266

-805

-692

-624

-535

-396

-336

-286

-499

-500

-688

-921

-915

-928

-809

-630

-490

-459

-532

-588

-721

-759

-641

-753

-532

-568

-710

-542

0

0

0

Cash flows from financing activities
Proceeds from stock option exercises

212

207

291

317

269

202

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of finance lease liabilities

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from stock options/warrants exercised

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

7,249

7,195

7,030

7,048

48

24

18

0

0

0

0

-

-

-

-

Change in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-60

-60

0

-60

-59

-59

839

899

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of mortgage note payable

-

-

-

-

-

-

-

-

0

-

-239

-239

-238

-240

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of mortgage note payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-3,575

-3,532

-3,592

0

6

-64

-32

0

3,732

3,735

3,737

3,740

0

0

0

Proceeds from issuance of common shares, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,531

11,531

11,531

11,531

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of industrial revenue bonds

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,257

3,419

3,351

3,385

162

0

0

0

-

-

-

-

-

-

-

-

Repurchase of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

420

421

420

421

0

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by financing activities

95

147

289

-2,257

-2,365

-2,492

-2,689

-240

-240

-239

5,536

5,655

5,716

5,714

-60

-218

1,010

12,779

12,549

12,665

10,650

-1,144

6,086

6,058

6,816

6,886

-88

-110

-114

-130

-294

-297

-299

-302

0

0

0

Effect of exchange rates on cash

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net change in cash, cash equivalents and restricted cash

18,965

42,216

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net change in cash, cash equivalents and restricted cash

-

-

-

-

-

-

-

-

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net change in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,873

-4,763

-5,940

6,072

7,067

8,512

8,682

-2,191

3,634

3,017

2,952

3,762

-1,987

-2,425

-357

-718

-920

-731

-335

1,053

0

0

0

Cash paid for:
Interest

14

8

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Interest paid

-

-

-

-

-

-

-

-

-

-

-

0

151

-

163

128

156

158

160

162

163

151

135

148

168

195

228

232

229

232

-203

-219

-127

-237

0

0

0

Non cash financing activities:
Cashless exercise of stock options/warrants

-87

612

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease adoption

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Capitalization of Lease

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-